Clinical Trial Update: Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the cardiovascular effects of etanercept on the heart, veins, and arterial thickness in patients with ankylosing spondylitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: TERMINATED | Results posted: 2016-01-13